Adaptive and Genentech join forces to develop shared and personalized T cell–based therapies for cancer patients, validating the therapeutic potential of Adaptive’s platform.
Adaptive and Genentech join forces to develop shared and personalized T cell–based therapies for cancer patients, validating the therapeutic potential of Adaptive’s platform.